Long-term effect of hormone therapy on bone in early menopause: vertebral fractures after 20 years

References

• Melton LJ 3rd. How many women have osteoporosis now?. J Bone Miner Res 1995;10:175–7
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos Int 2005;16(Suppl 2):S3–7
   PubMed Web of Science ®Google Scholar
• Pirro M, Fabbriciani G, Leli C, et al. High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab 2010;28:88–93
   PubMed Web of Science ®Google Scholar
• Briggs AM, Greig AM, Wark JD. The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int 2007;18:575–84
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Stevenson JC. The WHI: the effect of hormone replacement therapy on fracture prevention. Climacteric 2012; 15:263–6
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012;19:257–71
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305:1305–14
   PubMed Web of Science ®Google Scholar
• Heiss G, Wallace R, Anderson GL, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008;299:1036–45
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Figueras F, Sanjuan A, et al. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause 1999;6:307–11
   PubMed Web of Science ®Google Scholar
• Studd J. Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60. Climacteric 2009; 12:206–9
   PubMed Web of Science ®Google Scholar
• Pines A, Sturdee DW, Birkhäuser MH, Schneider HPG, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007;10:181–94
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Martínez de Osaba MJ, Pons F, González-Merlo J. The effect of hormone replacement therapy on postmenopausal bone loss. Eur J Obstet Gynecol Reprod Biol 1992;44:131–6
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Pons F, González-Merlo J. Bone mineral density in surgically postmenopausal women receiving hormonal replacement therapy as assessed by dual photon absorptiometry. Maturitas 1993;16:133–7
   PubMed Web of Science ®Google Scholar
• Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137–48
   PubMed Web of Science ®Google Scholar
• Calaf i Alsina J. Benefits of hormone replacement therapy – overview and update. Int J Fertil Womens Med 1997;42(Suppl 2): 329–46
   PubMedGoogle Scholar
• Writing Group for the PEPI. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1996;276:1389–96
   PubMed Web of Science ®Google Scholar
• Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med 1991;325:1189–95
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Pons F, Vicente JJ, Sanjuán A, Vanrell JA. Preventing postmenopausal bone loss with ossein-hydroxyapatite compounds. Results of a two-year, prospective trial. J Reprod Med 1999;44:601–5
   PubMed Web of Science ®Google Scholar
• Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. BMC Musculoskelet Disord 2001;2:7
   PubMedGoogle Scholar
• Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980;2: 1151–4
   PubMed Web of Science ®Google Scholar
• Lufkin EG, Wahner HW, O’Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;117:1–9
   PubMed Web of Science ®Google Scholar
• Banks E, Beral V, Reeves G, Balkwill A, Barnes I. Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA 2004;291:2212–20
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Emkey RD, Bone HG, et al. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002;137:875–83
   PubMed Web of Science ®Google Scholar
• Bea JW, Zhao Q, Cauley JA, et al. Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials. Menopause 2011;18:44–52
   PubMed Web of Science ®Google Scholar
• Wu F, Ames R, Clearwater J, Evans MC, Gamble G, Reid IR. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin Endocrinol (Oxf) 2002;56:703–11
   PubMed Web of Science ®Google Scholar
• Balasch J. Sex steroids and bone: current perspectives. Hum Reprod Update 2003;9:207–22
   PubMed Web of Science ®Google Scholar
• Marcus R. Post-menopausal osteoporosis. Best Pract Res Clin Obstet Gynecol 2002;16:309–27
   PubMed Web of Science ®Google Scholar